| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.0130238833303634 | 0.34793252 |
| NSC 688228 | Null | 0.0130238833303634 | 0.12748799 |
| NSC 6926 | Null | 0.0130238833303634 | 0.25378962 |
| NSC 693037 | Null | 0.0130238833303634 | 0.12281079 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0130238833303634 | 0.12492651 |
| NSC 718781 | Erlotinib hydrochloride | 0.0130238833303634 | -0.14980528 |
| NSC 726217 | Combretastatin A4-analogue | 0.0130238833303634 | 0.44686708 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0130238833303634 | 0.31528928 |
| NSC 740357 | Null | 0.0130238833303634 | -0.11877631 |
| NSC 87864 | N-Salicylidene-N-salicyloylhydrazine | 0.0130238833303634 | 0.20219001 |